Category Archives: Publications & Research
Restrictions Sought on Fingolimod for MS
The Institute for Safe Medication Practices (ISMP) has asked the US Food and Drug Administration (FDA) to restrict the use of fingolimod (Gilenya, Novartis) in patients with multiple sclerosis (MS), due to adverse event reports.
CCSVI Study Moved Forward by Federal Government
The benefits of CCSVI Treatment have been touted by Saskatchewan residents who’ve travelled the abroad to have it. They say it makes a huge difference to their MS symptoms. The federal government has now taken another step towards their own … Continue reading
Having a Doppler Ultrasound
At Angeles Health Chronic Cerebrospinal Venous Insufficiency (CCSVI), the vascular condition linked with MS, is diagnosed using a combination of Magnetic Resonance Venography (MRV) and Doppler Ultrasound. Research has examined the effectiveness of MRV compared to Doppler Ultrasound and selective … Continue reading
Click to Chat